Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 5
2006 5
2007 5
2008 4
2009 4
2010 5
2011 3
2012 1
2013 4
2014 6
2015 7
2016 8
2017 17
2018 9
2019 15
2020 18
2021 26
2022 23
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Early REperfusion Therapy with Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion (REVISION): Study Protocol of a Phase III Trial.
Poli S, Grohmann C, Wenzel DA, Poli K, Tuennerhoff J, Nedelmann M, Fiehler J, Agostini H, Campbell B, Fischer DM, Sykora M, Mac Grory B, Feltgen N, Seiffge DJ, Strbian D, Schultheiß M, Spitzer MS. Poli S, et al. Among authors: feltgen n. Int J Stroke. 2024 Apr 9:17474930241248516. doi: 10.1177/17474930241248516. Online ahead of print. Int J Stroke. 2024. PMID: 38591748
Intravitreal Injections: Improving Sustainability by Reducing Clinical Waste.
Birtel J, Hammer M, Feltgen N, Pauleikhoff L, Ong AY, Geerling G, Spitzer MS, Charbel Issa P. Birtel J, et al. Among authors: feltgen n. Klin Monbl Augenheilkd. 2024 Apr 4. doi: 10.1055/a-2184-9492. Online ahead of print. Klin Monbl Augenheilkd. 2024. PMID: 38574679 English, German.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
LASER FLARE PHOTOMETRY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT: An Evaluation of 2,487 Cases.
Gietzelt C, Hoerster R, Schiller P, Hermann S, Kraus D, Holz FG, Guthoff R, Agostini H, Spitzer MS, Wiedemann P, Lommatzsch A, Boden KT, Bartz-Schmidt U, Bemme S, Tamm S, Maier M, Roider J, Kirchhof B, Fauser S, Schaub F; PRIVENT Study Group. Gietzelt C, et al. Retina. 2024 May 1;44(5):764-773. doi: 10.1097/IAE.0000000000004026. Retina. 2024. PMID: 38181515 Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
[Chronic eye pain].
Erlenwein J, Petzke F, Tavernini T, Heindl LM, Feltgen N. Erlenwein J, et al. Among authors: feltgen n. Ophthalmologie. 2023 Dec;120(12):1216-1225. doi: 10.1007/s00347-023-01957-8. Epub 2023 Nov 24. Ophthalmologie. 2023. PMID: 37999754 Review. German.
[Chronic pain in ophthalmology].
Erlenwein J, Feltgen N. Erlenwein J, et al. Among authors: feltgen n. Ophthalmologie. 2023 Dec;120(12):1202-1203. doi: 10.1007/s00347-023-01950-1. Epub 2023 Nov 6. Ophthalmologie. 2023. PMID: 37930370 German. No abstract available.
161 results